Case Studies 4

A development stage biotechnology company engaged Easton Associates to assess the market landscape and quantify the U.S. revenue opportunity for their Phase II thrombolytic agent in development for the treatment of acute ischemic stroke. EA delivered a concise overview of the stroke market including disease background, patient segmentation, current treatment algorithms and clinician reactions to the target product profile. At the conclusion of this engagement, EA provided the client with expected revenue forecasts and a development strategy to enhance the positioning of this agent and maximize its market potential.